Santa Cruz Biotechnology delivers a wide array of Calgranulin C monoclonal antibodies for various research applications. Calgranulin C monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Calgranulin C, also known as S100A8, plays a crucial role in the regulation of inflammatory processes and is involved in the immune response. It is primarily expressed in myeloid cells and is known to interact with various receptors, influencing cell signaling pathways. The study of Calgranulin C is essential for understanding its implications in diseases such as cancer and inflammatory disorders. Calgranulin C monoclonal antibodies enable precise detection and quantification of S100A8 expression levels across different cell types and tissues. Researchers investigating inflammatory pathways and immune responses can leverage Calgranulin C monoclonal antibodies to advance their experimental work. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies for Calgranulin C support researchers in making meaningful contributions to understanding inflammatory diseases and potential therapeutic approaches.